Advanced BioMedical Technologies (Advanced BioMedical Technologies) Tangible Book per Share : $-0.12 (As of Jul. 2021)

Advanced BioMedical Technologies Tangible Book per Share Chart

Advanced BioMedical Technologies Annual Data
	Trend	Oct11	Oct12	Oct13	Oct14	Oct15	Oct16	Oct17	Oct18	Oct19	Oct20
Tangible Book per Share		Get a 7-Day Free Trial					-0.07	-0.07	-0.08	-0.09	-0.11

Advanced BioMedical Technologies Quarterly Data
	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21
Tangible Book per Share	Get a 7-Day Free Trial															-0.10	-0.11	-0.11	-0.11	-0.12

Competitive Comparison of Advanced BioMedical Technologies's Tangible Book per Share

For the Medical Devices subindustry, Advanced BioMedical Technologies's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced BioMedical Technologies's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced BioMedical Technologies's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Advanced BioMedical Technologies's Price-to-Tangible-Book falls into.

Advanced BioMedical Technologies Tangible Book per Share Calculation

Advanced BioMedical Technologies's Tangible Book Value Per Share for the fiscal year that ended in Oct. 2020 is calculated as

Advanced BioMedical Technologies's Tangible Book Value Per Share for the quarter that ended in Jul. 2021 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total equity is a balance sheet item and equal to total assets less total liabilities of the company. Since intangibles such as goodwill cannot be sold when the company liquidates, tangible book value per share is considered more accurate in reflecting how much shareholders will receive when the company liquidates.

Advanced BioMedical Technologies  (OTCPK:ABMT) Tangible Book per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Advanced BioMedical Technologies Tangible Book per Share Related Terms

Thank you for viewing the detailed overview of Advanced BioMedical Technologies's Tangible Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced BioMedical Technologies (Advanced BioMedical Technologies) Business Description